A follow-up path definition method and system
By calculating the comprehensive matching value of the follow-up target, combining physical condition and medication, personalized follow-up examination and investigation are provided, the problem of timely exclusion and matching accuracy in the follow-up path is solved, and the matching accuracy and medication of the follow-up items are improved Treatment effect.
Patent Information
- Application Number
- CN202410305067.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-18
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-03-18
AI Technical Summary
The inclusion and exclusion mechanism of follow-up items in the existing follow-up path lacks timely, matching lacks accuracy, and the follow-up targets cannot be accurately included in the appropriate follow-up items, resulting in the follow-up content being unable to be adjusted in time based on the progress of the follow-up target's condition, and the data collection of medication status is not comprehensive enough. , reducing the accuracy of follow-up item matching.
By calculating the comprehensive matching value of the follow-up targets, it reflects the degree of matching between the follow-up target information data and the follow-up item, and combines physical condition and medication data, it provides personalized follow-up examinations and investigations to promptly understand and supervise the medication status of the follow-up targets, and improves the medication status of the follow-up targets. Drug treatment effect.
The timely inclusion and exclusion of follow-up items and the accuracy of matching are improved, the follow-up content is adjusted in a timely manner, the rehabilitation and prognosis of the follow-up targets are improved, and the effectiveness and safety of drug treatment are improved.
Smart Images

Figure CN118072915B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of follow-up paths, and in particular to a follow-up path definition method and system. Background Art
[0002] With the development of medical technology and the improvement of people's health awareness, the requirements for the quality of medical services are getting higher and higher. Follow-up target follow-up, as an important part of medical services, can help medical institutions understand the recovery status of the follow-up target, adjust the treatment plan in time, and improve the treatment effect and satisfaction of the follow-up target. The follow-up path refers to a set of standardized and normalized follow-up processes formulated during the treatment of the follow-up target based on the type, severity, treatment method of the disease and the overall health status of the follow-up target. With the advancement of hospital informatization construction, it is necessary to provide a follow-up path definition method and system to improve the efficiency and effectiveness of follow-up work.
[0003] For example, the invention patent with announcement number CN112906973B discloses a method and system for recommending a family doctor follow-up path. First, relevant information of doctors and follow-up targets is collected and preprocessed; then a doctor follow-up path optimization model is constructed based on decision variables, objective functions and constraints; finally, an exhaustive method or optimization algorithm is used to solve the doctor follow-up path optimization model, and the optimal follow-up path, follow-up mode, follow-up group and follow-up duration are pushed out. Compared with existing follow-up technologies, this application can greatly reduce the time doctors spend on the road and improve follow-up efficiency.
[0004] For example, the invention patent with announcement number CN106453619B discloses a network-based intelligent follow-up system for cardiovascular diseases, whose technical features include: including a follow-up target client, a doctor client, a central data management client and a central data platform; the follow-up target client and the doctor client are connected to the central data platform through a network, and a follow-up relationship between the follow-up target client and the doctor client is established and the follow-up function is implemented through the central data platform. The central data management client is connected to the central data platform to realize the follow-up management function. This application connects the follow-up target client and the doctor client to the central data through the network to quickly establish a follow-up relationship, and realizes the functions of quick and automatic input of various follow-up target data, targeted transmission of follow-up target data between the follow-up target and its doctor, and automatic message template generation for the doctor's reply to the follow-up target, thereby improving the efficiency and accuracy of follow-up, reducing the cost of follow-up, and expanding the application scenarios of follow-up.
[0005] At present, there are still some shortcomings in the follow-up path, which are specifically reflected in the following aspects: (1) The inclusion and exclusion mechanism of follow-up items in the current follow-up path lacks timeliness, and the matching of follow-up items lacks precision. It is impossible to accurately include follow-up targets in appropriate follow-up projects, resulting in the inability to make timely changes to the follow-up content according to the progression of the follow-up target's condition. Users may not be able to accurately understand the real-time health data information of the follow-up target.
[0006] (2) The current follow-up content focuses more on collecting the physical condition data of the follow-up targets, while the collection of the medication status data of the follow-up targets is somewhat neglected. Medication status data is an important component of the follow-up project matching data. If the collection of medication status data is not comprehensive, it will reduce the accuracy of follow-up project matching. Summary of the invention
[0007] In view of the deficiencies in the prior art, the present invention provides a follow-up path definition method and system, which can effectively solve the problems involved in the above-mentioned background technology.
[0008] To achieve the above objectives, the present invention is implemented through the following technical solutions: The first aspect of the present invention provides a follow-up path definition method, including: step one, analyzing the follow-up target status, and calculating the follow-up target comprehensive matching value of the follow-up target, wherein the follow-up target comprehensive matching value is used to reflect the matching degree between the follow-up target information data and the follow-up item.
[0009] Step 2: Match the follow-up items to the follow-up targets, and conduct a cyclic analysis of the follow-up items for the follow-up targets.
[0010] As a further method, the status of the follow-up target is analyzed. The specific analysis process is: obtaining basic information of the follow-up target, wherein the basic information of the follow-up target includes the gender data, age data, height data and weight data of the follow-up target, generating a specified label for the gender and age of the follow-up target, and Calculate the body mass index of the follow-up target, where represents the body mass index of the follow-up target, and Represent the height and weight of the follow-up target, respectively.
[0011] The body mass index of the follow-up target is matched with the reference standard values of various physical indicators corresponding to each labeled follow-up target in each body mass index range stored in the medical information database to obtain the reference standard values of various physical indicators of the follow-up target, including the reference standard heart rate, reference standard body temperature, reference standard blood pressure, reference standard daily exercise duration, reference standard daily exercise steps, reference standard blood oxygen saturation after taking medication, reference standard sleep duration during medication, reference standard medication time interval and medication dosage.
[0012] As a further method, the formula for calculating the comprehensive matching value of the follow-up target is as follows: , where represents the comprehensive matching value of the follow-up target, and They represent the physical sign data matching index and the drug taking data matching index of the follow-up target, represents a natural constant, and They respectively represent the comprehensive matching influencing factors corresponding to the set physical sign data matching degree index and medication data matching degree index.
[0013] As a further method, the calculation expression of the physical sign data matching degree index is: , where Represents the matching degree index of physical sign data, and They represent the matching evaluation value of the vital sign data and the matching evaluation value of the motion data of the follow-up target, and They respectively represent the basic vital sign influencing factors corresponding to the set vital sign data matching evaluation value and motion data matching degree evaluation value.
[0014] As a further method, the vital sign data matching evaluation value is specifically analyzed and calculated as follows: obtaining the vital sign data of the follow-up target, deploying several detection time points within the set detection cycle, obtaining the heart rate data, body temperature data and blood pressure data of the follow-up target at each detection time point, and comprehensively calculating the vital sign data matching evaluation value, and its calculation expression is: , where Represents the vital signs data matching evaluation value, , and Respectively indicate the follow-up targets in Heart rate, body temperature and blood pressure at each test time point. , and Represents the reference standard heart rate, reference standard body temperature and reference standard blood pressure respectively. , and They represent the set limit deviation heart rate, limit deviation body temperature and limit deviation blood pressure respectively. , and They represent the abnormal vital sign influencing factors corresponding to the set heart rate, body temperature and blood pressure, respectively. Indicates the number of each detection time point, , Indicates the total number of detection time points.
[0015] As a further method, the motion data matching degree evaluation value has a specific analysis process of: investigating and obtaining the motion data of the follow-up target, including the exercise duration and number of exercise steps of the follow-up target on each exercise day, and comprehensively calculating the motion data matching degree evaluation value, and the calculation expression thereof is: , where Represents the motion data matching evaluation value, and Respectively represent The exercise duration and number of steps per exercise day, and They represent the reference standard daily exercise duration and the reference standard daily exercise steps, and They represent the set limit deviation movement duration and limit deviation movement steps respectively. and They represent the influencing factors of the matching degree of exercise data corresponding to the set exercise duration and exercise steps, respectively. Indicates the number of each sports day, , Indicates the total number of sports days.
[0016] As a further method, the drug administration data matching degree index is calculated as follows: , where Indicates the matching degree index of drug administration data, and Represent the abnormal drug response value and the drug compliance assessment value, respectively. and They respectively represent the abnormal medication impact factors corresponding to the set abnormal drug reaction values and drug compliance assessment values.
[0017] As a further method, the specific analysis process of the abnormal drug reaction value is as follows: deploy a number of time screening points, obtain the blood oxygen saturation of the follow-up target at each time screening point during the medication period, and simultaneously detect the average heart rate and average blood pressure of the follow-up target after each medication.
[0018] The follow-up target's sleep duration and number of nighttime awakenings on each medication day were obtained.
[0019] Calculate the abnormal physical sign evaluation value after taking the medicine, and its calculation expression is: , calculate the abnormal sleep quality evaluation value after taking the medicine, and its calculation expression is: , comprehensively calculate the abnormal value of drug reaction, and its calculation expression is: , where Indicates the evaluation value of abnormal physical signs after taking the medicine. The follow-up target is during the medication period. The target's blood oxygen saturation is followed up at each time screening point. Indicates the reference standard blood oxygen saturation after taking the drug. Indicates the set blood oxygen saturation limit deviation. Indicates the abnormal drug reaction impact factor corresponding to the set blood oxygen saturation. and Respectively represent The average heart rate and average blood pressure of the follow-up target after the first dose of medication, and Represent the reference standard heart rate and reference standard blood pressure, respectively. and They represent the set medication deviation heart rate and medication deviation blood pressure, respectively. Indicates the number of each time screening point, , represents the total number of time screening points, Indicates the number of each dose of medication. , Indicates the total number of times the medication is taken. It indicates the abnormal sleep quality assessment value after taking the medicine. The follow-up target is The duration of sleep on each medication day, It means that the standard sleep duration should be referred to during medication. Indicates the allowable deviation of the sleep duration during medication. The follow-up target is Number of nighttime awakenings per medication day, Indicates the sleep quality influencing factor corresponding to the set sleep duration. Indicates the sleep quality impact factor corresponding to a single night awakening. Indicates the number of each medication day, , Indicates the total number of medication days, Indicates abnormal drug response values, and They respectively represent the abnormal drug reaction influencing factors corresponding to the set abnormal physical sign assessment values after taking medication and the abnormal sleep quality assessment values after taking medication.
[0020] As a further method, the specific analysis process of the drug compliance evaluation value is: setting a follow-up period, and obtaining the time interval and dosage of each medication of the follow-up target within the period.
[0021] The drug compliance evaluation value is calculated comprehensively, and the calculation expression is: , where represents the medication compliance assessment value, and Respectively represent Class II The interval between doses and the dosage of the medication. and Respectively represent The reference standard medication interval and dosage of the drug class, and They represent the set medication time interval and medication dosage respectively. and They respectively represent the drug compliance influencing factors corresponding to the set medication time interval and medication dosage.
[0022] As a further method, the follow-up target is matched with follow-up items, and the specific analysis process is: obtaining the follow-up target comprehensive matching value of the follow-up target, matching the follow-up target comprehensive matching value of the follow-up target with the follow-up target comprehensive matching value interval corresponding to each follow-up item stored in the medical information library, obtaining the follow-up item corresponding to the follow-up target, and incorporating the follow-up target into the corresponding follow-up item.
[0023] The second aspect of the present invention provides a follow-up path definition system, including: a follow-up target status analysis module, used to analyze the follow-up target status and calculate the follow-up target comprehensive matching value of the follow-up target, wherein the follow-up target comprehensive matching value is used to reflect the matching degree between the follow-up target information data and the follow-up item.
[0024] The follow-up project matching module is used to match the follow-up projects to the follow-up targets and to perform a follow-up project cycle analysis on the follow-up targets.
[0025] The medical information database is used to store the reference standard values of various physical indicators corresponding to each label follow-up target in each body mass index interval, and the comprehensive matching value interval of the follow-up target corresponding to each follow-up item.
[0026] Compared with the prior art, the embodiments of the present invention have at least the following advantages or beneficial effects: (1) The present invention provides a follow-up path definition method and system, obtains the physical condition data of the follow-up target, provides a parameter calculation method, and comprehensively calculates the follow-up target comprehensive matching value of the follow-up target, wherein the follow-up target comprehensive matching includes physical condition data collection and medication status investigation, and according to the basic information and body mass index of the follow-up target, the reference standard values of various physical indicators of the follow-up target are matched, and personalized follow-up examinations are provided, and follow-up investigations are conducted on the medication status of the follow-up target, so as to timely understand and supervise the medication status of the follow-up target and improve the effect of drug treatment.
[0027] (2) The present invention comprehensively calculates the comprehensive matching value of the follow-up target for quantitatively evaluating the physical condition of the follow-up target. At the same time, the comprehensive matching value of the follow-up target provides data support for the inclusion and exclusion of follow-up items, thereby improving the timeliness of the inclusion and exclusion of follow-up items and the accuracy of the matching of follow-up items, and facilitating timely adjustment of the follow-up content according to the progression of the follow-up target's condition, thereby improving the rehabilitation and prognosis of the follow-up target.
[0028] (3) The present invention matches the reference standard values of various physical indicators of the follow-up target based on the basic information and body mass index of the follow-up target, provides personalized follow-up examinations, and quantifies the basic information of the follow-up target, which helps to improve the accuracy of personalized follow-up examinations. At the same time, the follow-up plan can be adjusted in time according to changes in the physical condition data of the follow-up target.
[0029] (4) The present invention improves the accuracy of matching the follow-up target with the follow-up items by investigating and analyzing the medication status of the follow-up target. At the same time, a follow-up investigation is conducted on the medication status of the follow-up target, so that the medication status of the follow-up target can be timely understood and supervised, thereby improving the effect of drug treatment. The drug dosage can also be adjusted according to the physical condition of the follow-up target, thereby reducing the probability of drug side effects and avoiding damage to the physical health of the follow-up target. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] The present invention is further described using the accompanying drawings, but the embodiments in the accompanying drawings do not constitute any limitation to the present invention. A person skilled in the art can obtain other drawings based on the following drawings without creative work.
[0031] Figure 1 It is a schematic diagram of the method flow of the present invention.
[0032] Figure 2 It is a schematic diagram of system module connection of the present invention. DETAILED DESCRIPTION
[0033] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.
[0034] Reference Figure 1 As shown, the first aspect of the present invention provides a follow-up path definition method, including: analyzing the follow-up target status, calculating the follow-up target comprehensive matching value of the follow-up target, and the follow-up target comprehensive matching value is used to reflect the matching degree between the follow-up target information data and the follow-up item.
[0035] In a specific embodiment, the process of creating a follow-up project by the intelligent follow-up system is as follows: click to create a project, enter the project name and brief description in the pop-up dialog box, click the project in the "Project Management" column to enter the newly created project, and after entering the project, click the "Project Design" item. In the "Indicator Editing", move to the content that needs to be modified, and a pen icon will appear. Click the icon to edit the content. After modifying the content, click the OK icon to complete the content modification.
[0036] In a specific embodiment, the intelligent follow-up system can be used to add follow-up targets in the follow-up project, and a regular and quantitative follow-up plan can be specified for different project research subjects. In the "Case Management", click on the case to light up the small bubble in front of the case row in green. At the same time, there will be three more buttons below the case list. Click the "Add Project" button to pop up a drop-down box for selecting a project. You can select an existing project in the drop-down box to add the case, or you can enter the project name in the input box and click the "Create a New Project and Add" button to create a new project and add the case to the project. If you enter the project name and click the "Create a New Project and Add" button, a newly created project will be added to the "Project Management", and the selected case will be added to this project. If you select an existing project, the case will be added to the existing project.
[0037] Specifically, the formula for calculating the comprehensive matching value of the follow-up target is as follows: , where represents the comprehensive matching value of the follow-up target, and They represent the physical sign data matching index and the drug taking data matching index of the follow-up target, represents a natural constant, and They respectively represent the comprehensive matching influencing factors corresponding to the set physical sign data matching degree index and medication data matching degree index.
[0038] It should be explained that in this embodiment, the specificity of the physical condition data of the follow-up target is reflected by the comprehensive matching value of the follow-up target, and the follow-up items are matched according to the specificity of the follow-up target. The greater the difference between the physical sign data and medication data of the follow-up target and the reference standard value, the higher the specificity of the follow-up target and the greater the comprehensive matching value of the follow-up target. At the same time, the influencing factors of the physical sign data and medication data are introduced to reflect the influence of the physical sign data and medication data on the comprehensive matching value of the follow-up target, thereby improving the accuracy of the result calculation. It should be explained that in this embodiment, the medication data matching degree index is used to reflect the medication information of the follow-up target, wherein the medication data matching degree index is obtained by investigating the drug response and drug compliance assessment of the follow-up target. Correct and timely medication is the key to the treatment effect of many diseases. If the follow-up target fails to take the medication correctly as prescribed by the doctor, it may lead to worsening of the condition or poor treatment effect. At the same time, some drugs may have side effects or interact with other drugs, increasing the health risks of the follow-up target. By understanding the medication situation of the follow-up target, the doctor can better assess the health risks of the follow-up target, formulate appropriate treatment plans and intervention measures, and at the same time help supervise and improve the medication habits of the follow-up target, improve treatment compliance, and reduce health risks.
[0039] In a specific embodiment, the comprehensive matching value of the follow-up target is comprehensively calculated to quantitatively evaluate the physical condition of the follow-up target. At the same time, data support is provided for the inclusion and exclusion of follow-up items based on the comprehensive matching value of the follow-up target, thereby improving the timeliness of the inclusion and exclusion of follow-up items and the accuracy of the matching of follow-up items, and facilitating timely adjustment of the follow-up content according to the development of the follow-up target's condition, thereby improving the rehabilitation and prognosis of the follow-up target.
[0040] Specifically, the following steps are performed to analyze the status of the follow-up target: obtaining basic information of the follow-up target, wherein the basic information of the follow-up target includes the gender data, age data, height data and weight data of the follow-up target, generating a designated label for the gender and age of the follow-up target, and Calculate the body mass index of the follow-up target, where represents the body mass index of the follow-up target, and Represent the height and weight of the follow-up target, respectively.
[0041] In a specific embodiment, the intelligent follow-up system includes an indicator management module, which is mainly used for the management, increase and decrease of various indicators, and the custom addition of user-applicable indicators. Users can click to define new indicators to add custom global indicators according to actual project needs, and edit the indicators. The editing includes several attributes, including: Single choice: represents the specific single choice of each indicator, such as indicators named gender, month, day of the week, etc.; Multiple choice: represents the specific multiple choice of each indicator, such as indicators such as hobbies; Value: represents the value of the variable in the indicator, and the indicator that needs to express the growth trend with numbers (when the number has only two increasing digits, it represents the range, which can be used as an early warning reminder), such as indicators named body temperature, height, age, etc.; Text: refers to options that do not include the above three attributes. For example, indicators named notes; Time: indicators that represent time and date. For example, discharge time, admission time, etc.; Picture: indicators that can save pictures, such as chest X-rays, avatars, etc.
[0042] The body mass index of the follow-up target is matched with the reference standard values of various physical indicators corresponding to each labeled follow-up target in each body mass index range stored in the medical information database to obtain the reference standard values of various physical indicators of the follow-up target, including the reference standard heart rate, reference standard body temperature, reference standard blood pressure, reference standard daily exercise duration, reference standard daily exercise steps, reference standard blood oxygen saturation after taking medication, reference standard sleep duration during medication, reference standard medication time interval and medication dosage.
[0043] It should be explained that in this embodiment, designated labels are generated for the gender and age of the follow-up target. Through the classification of gender and age, medical personnel can pay attention to and detect possible health risks of the follow-up target based on common health problems of different genders and age groups. At the same time, classified detection of follow-up targets of different genders and ages helps to detect diseases at an early stage, which can increase the chances of successful treatment, reduce treatment costs, and alleviate the pain of the follow-up target.
[0044] It should be explained that in this embodiment, the reference standard body indicators of the follow-up target are obtained based on the body mass index matching of the follow-up target. The body mass index (BMI) is a commonly used indicator to measure the fatness and health of the human body. Classification and detection of whether the body data is normal based on the body mass index of the follow-up target plays an important role in assessing the health status of the individual. BMI is closely related to the risk of various chronic diseases such as cardiovascular disease, diabetes, hypertension, stroke and other diseases. Through the classification of BMI, the possible health risks of the individual can be predicted, so as to carry out early intervention and treatment. At the same time, according to the classification results of BMI, personalized health intervention measures can be formulated for the individual to improve the health status of the follow-up target.
[0045] In a specific embodiment, based on the basic information and body mass index of the follow-up target, the reference standard values of various physical indicators of the follow-up target are matched to provide personalized follow-up examinations. Quantifying the basic information of the follow-up target helps to improve the accuracy of personalized follow-up examinations. At the same time, the follow-up plan can be adjusted in time according to changes in the physical condition data of the follow-up target.
[0046] Furthermore, the calculation expression of the physical sign data matching degree index is: , where Represents the matching degree index of physical sign data, and They represent the matching evaluation value of the vital sign data and the matching evaluation value of the motion data of the follow-up target, and They respectively represent the basic vital sign influencing factors corresponding to the set vital sign data matching evaluation value and motion data matching degree evaluation value.
[0047] It should be explained that the vital signs data matching evaluation value in this embodiment is used to reflect the specificity of the basic vital signs of the follow-up target. The greater the gap between the vital signs data of the follow-up target and the reference standard data, the higher the specificity and the greater the vital signs data matching evaluation value of the follow-up target. The basic vital signs data are important indicators reflecting the physical condition data of the follow-up target. Obtaining vital signs data helps to improve the accuracy of follow-up item matching.
[0048] It should be explained that, in this embodiment, the motion data matching degree evaluation value is used to reflect the physical rehabilitation data and the exercise habit data of the follow-up target, and can be matched to obtain the reference standard motion data of the beneficial rehabilitation of the follow-up target. The greater the difference between the motion data of the follow-up target and the reference standard value, the worse the physical rehabilitation effect, and the greater the motion data matching degree evaluation value of the follow-up target. The follow-up plan can be adjusted in time according to the motion data matching degree evaluation value.
[0049] It should be explained that in this embodiment, by monitoring the matching degree index of the vital sign data of the follow-up target, the specific situation of the follow-up target can be well monitored. The influencing factors corresponding to the vital sign data and the motion data can reflect the influence of the vital sign data and the motion data on the matching degree index of the vital sign data to a certain extent, thereby improving the accuracy of the final data calculation.
[0050] Specifically, the vital sign data matching evaluation value is specifically analyzed and calculated as follows: obtaining the vital sign data of the follow-up target, deploying several detection time points within the set detection cycle, obtaining the heart rate data, body temperature data and blood pressure data of the follow-up target at each detection time point, and comprehensively calculating the vital sign data matching evaluation value, and its calculation expression is: , where Represents the vital signs data matching evaluation value, , and Respectively indicate the follow-up targets in Heart rate, body temperature and blood pressure at each test time point. , and Represents the reference standard heart rate, reference standard body temperature and reference standard blood pressure respectively. , and They represent the set limit deviation heart rate, limit deviation body temperature and limit deviation blood pressure respectively. , and They represent the abnormal vital sign influencing factors corresponding to the set heart rate, body temperature and blood pressure, respectively. Indicates the number of each detection time point, , Indicates the total number of detection time points.
[0051] It should be explained that the calculation expression of the vital signs data matching evaluation value in the present embodiment calculates the difference between the heart rate data, body temperature data and blood pressure data and the reference standard value respectively, which can reflect the specific situation of each vital signs data of the follow-up target. The set difference of each vital signs data is introduced into the formula for ratio calculation, which can unify the units of each vital signs data and eliminate the influence of different units on the result calculation. At the same time, the influence factor of each vital signs data is substituted to reflect the influence of different vital signs data on the vital signs data matching evaluation value, thereby improving the accuracy of data calculation.
[0052] It should be explained that in this embodiment, the heart rate of the follow-up target is detected. The heart rate is a reflection of the heartbeat, reflecting the heart's pumping function and the health of the heart. A heart rate that is too fast, too slow or irregular may be related to heart disease, electrolyte disorders or nervous system problems. By detecting the heart rate, data information related to the heart or nervous system of the follow-up target can be collected to improve the physical data modeling of the follow-up target.
[0053] It should be explained that in this embodiment, the body temperature of the follow-up target is detected. Body temperature is a direct reflection of the human body's metabolism and disease status. The normal body temperature range is 36.1°C-37.2°C. Elevated body temperature may indicate infection, inflammation or other pathological conditions, while low body temperature may indicate problems such as slowed metabolism or endocrine disorders.
[0054] It should be explained that in this embodiment, the follow-up target blood pressure is tested. Blood pressure is an important indicator reflecting the function of the cardiovascular system. The normal blood pressure range is 120 / 80 mmHg. Hypertension may lead to health problems such as cardiovascular disease and kidney disease, while hypotension may be related to heart disease, anemia or endocrine disorders.
[0055] Specifically, the motion data matching degree evaluation value has a specific analysis process of: investigating and obtaining the motion data of the follow-up target, including the exercise duration and number of exercise steps of the follow-up target on each exercise day, and comprehensively calculating the motion data matching degree evaluation value, and the calculation expression thereof is: , where Represents the motion data matching evaluation value, and Respectively represent The exercise duration and number of steps per exercise day, and They represent the reference standard daily exercise duration and the reference standard daily exercise steps, and They represent the set limit deviation movement duration and limit deviation movement steps respectively. and They represent the influencing factors of the matching degree of exercise data corresponding to the set exercise duration and exercise steps, respectively. Indicates the number of each sports day, , Indicates the total number of sports days.
[0056] It should be explained that the calculation expression for the motion data matching degree evaluation value in this embodiment calculates the difference between the exercise duration and the number of exercise steps and the reference standard value, which can reflect the specific situation of each motion data of the follow-up target. The set difference of each motion data is introduced into the formula for ratio calculation, which can unify the unit of the motion data and eliminate the influence of different units on the result calculation. At the same time, the influence factor of each motion data is substituted to reflect the influence of different motion data on the motion data matching degree evaluation value, thereby improving the accuracy of data calculation.
[0057] It should be explained that in this embodiment, the motion data of the follow-up target is investigated and obtained. Understanding the motion data of the follow-up target can help doctors understand the physical activity of the follow-up target during and after treatment, thereby formulating a more personalized rehabilitation plan for the patient and improving the quality of life.
[0058] Specifically, the calculation expression of the drug administration data matching degree index is: , where Indicates the matching degree index of drug taking data, and Represent the abnormal drug response value and the drug compliance assessment value, respectively. and They respectively represent the abnormal medication impact factors corresponding to the set abnormal drug reaction values and drug compliance assessment values.
[0059] It should be explained that in this embodiment, the specificity of the medication data of the follow-up target is reflected by the medication data matching degree index. The greater the difference between the medication response and medication compliance of the follow-up target and the reference standard value, the higher the specificity of the medication data of the follow-up target and the larger the medication data matching degree index. At the same time, the influencing factors of drug response and medication compliance are introduced to reflect the influence of drug response and medication compliance on the medication data matching degree index, thereby improving the accuracy of the result calculation.
[0060] It should be explained that the abnormal drug response value in this embodiment is used to evaluate the abnormal drug response of the follow-up target's body. By performing drug response testing on the follow-up target, the sensitivity and tolerance of the follow-up target to the drug can be timely understood, thereby providing a basis for clinicians to formulate appropriate treatment plans. Reasonable use of drugs can reduce the occurrence of adverse drug reactions and improve the safety and effectiveness of drug treatment.
[0061] It should be explained that the drug compliance assessment value in this embodiment is used to reflect the compliance of the follow-up target with the doctor's orders. The drug compliance survey can help understand whether the follow-up target takes the medicine on time and in the amount according to the doctor's advice and prescription. By improving the drug compliance of the follow-up target, the effect of drug treatment can be effectively improved, the recurrence rate of the disease can be reduced, and the consumption of medical resources can be reduced.
[0062] In a specific embodiment, by investigating and analyzing the medication status of the follow-up target, the accuracy of matching the follow-up target with the follow-up items is improved. At the same time, a follow-up investigation is conducted on the medication status of the follow-up target, so that the medication status of the follow-up target can be timely understood and supervised, the effect of drug treatment can be improved, and the drug dosage can be adjusted according to the physical condition of the follow-up target, thereby reducing the probability of drug side effects and avoiding damage to the physical health of the follow-up target.
[0063] Specifically, the specific analysis process of the abnormal drug reaction value is as follows: deploy several time screening points, obtain the blood oxygen saturation of the follow-up target at each time screening point during the medication period, and at the same time detect the average heart rate and average blood pressure of the follow-up target after each medication.
[0064] The follow-up target's sleep duration and number of nighttime awakenings on each medication day were obtained.
[0065] Calculate the abnormal physical sign evaluation value after taking the medicine, and its calculation expression is: , calculate the abnormal sleep quality evaluation value after taking the medicine, and its calculation expression is: , comprehensively calculate the abnormal value of drug reaction, and its calculation expression is: , where Indicates the evaluation value of abnormal physical signs after taking the medicine. The follow-up target is during the medication period. The target's blood oxygen saturation is followed up at each time screening point. Indicates the reference standard blood oxygen saturation after taking the drug. Indicates the set blood oxygen saturation limit deviation. Indicates the abnormal drug reaction impact factor corresponding to the set blood oxygen saturation. and Respectively represent The average heart rate and average blood pressure of the follow-up target after the first dose of medication, and Represent the reference standard heart rate and reference standard blood pressure, respectively. and They represent the set medication deviation heart rate and medication deviation blood pressure, respectively. Indicates the number of each time screening point, , represents the total number of time screening points, Indicates the number of each dose of medication. , Indicates the total number of times the medication is taken. It indicates the abnormal sleep quality assessment value after taking the medicine. The follow-up target is The duration of sleep on each medication day, It means that the standard sleep duration should be referred to during medication. Indicates the allowable deviation of the sleep duration during medication. The follow-up target is Number of nighttime awakenings per medication day, Indicates the sleep quality influencing factor corresponding to the set sleep duration. Indicates the sleep quality impact factor corresponding to a single night awakening. Indicates the number of each medication day, , Indicates the total number of medication days, Indicates abnormal drug response values, and They respectively represent the abnormal drug reaction influencing factors corresponding to the set abnormal physical sign assessment values after taking medication and the abnormal sleep quality assessment values after taking medication.
[0066] It should be explained that, in this embodiment, the abnormal drug reaction value is used to reflect the specific physical condition of the follow-up target after taking the medicine. The greater the difference between the physical sign data and sleep data of the follow-up target after taking the medicine and the reference standard value, the higher the specificity of the drug reaction of the follow-up target and the larger the abnormal drug reaction value. At the same time, the influencing factors of the physical sign data and sleep data are introduced to reflect the influence of the physical sign data and sleep data on the abnormal drug reaction value, thereby improving the accuracy of the result calculation.
[0067] It should be explained that in this embodiment, the blood oxygen saturation of the follow-up target after taking the medicine is detected. Blood oxygen saturation (SaO2) is an indicator to measure the degree of hemoglobin binding to oxygen in the blood, which can reflect the oxygen supply status of human tissues and organs. The monitoring of drug response usually focuses on the effect of the drug and its impact on the physiological function of the body. Changes in blood oxygen saturation can be used as an indicator to evaluate the therapeutic effect of certain drugs, especially for those drugs that affect the respiratory and circulatory systems.
[0068] It should be explained that in this embodiment, the heart rate and blood pressure of the follow-up target after taking the medicine are detected. Detecting the changes in the heart rate and blood pressure of the follow-up target after taking the medicine plays an important role in reflecting the drug response. Heart rate and blood pressure are key indicators for evaluating the function of the cardiovascular system. Changes in heart rate and blood pressure after taking the medicine can reflect the impact of the drug on the cardiovascular system and help doctors understand the efficacy and potential side effects of the drug.
[0069] It should be explained that in this embodiment, the sleep quality of the follow-up target after taking the medicine is tested. Sleep quality is an important indicator for evaluating drug response, especially for those drugs used to treat insomnia, anxiety, depression and other diseases. Sleep quality can reflect the efficacy of the drug and its impact on the central nervous system. Testing sleep quality can help doctors understand the efficacy and side effects of the drug and guide the use of the drug.
[0070] Furthermore, the specific analysis process of the medication compliance assessment value is: setting a follow-up period, and obtaining the medication time interval and medication dosage of each medication of the follow-up target within the period.
[0071] The drug compliance evaluation value is calculated comprehensively, and the calculation expression is: , where represents the medication compliance assessment value, and Respectively represent Class II The interval between doses and the dosage of the medication. and Respectively represent The reference standard medication interval and dosage of the drug class, and They represent the set medication time interval and medication dosage respectively. and They respectively represent the drug compliance influencing factors corresponding to the set medication time interval and medication dosage.
[0072] It should be explained that the calculation expression of the drug compliance assessment value in this embodiment calculates the difference between the medication time interval and the medication dosage and the reference standard value, which can reflect the specific situation of various medication data of the follow-up target. The set difference of various medication data is introduced into the formula for ratio calculation, which can unify the units of various data and eliminate the influence of different units on the result calculation. At the same time, the influencing factors of the medication time interval and medication dosage are substituted to reflect the influence of the medication time interval and medication dosage on the drug compliance assessment value, thereby improving the accuracy of data calculation.
[0073] It should be explained that in this embodiment, the medication dosage of the follow-up target is investigated. Detecting the medication dosage of the follow-up target helps to timely discover adverse reactions caused by irregular medication of the follow-up target, so as to timely adjust the treatment plan, alleviate the pain of the follow-up target, and reduce the incidence of adverse drug reactions. By detecting the medication dosage of the follow-up target, the medication compliance of the follow-up target can be effectively improved.
[0074] In a specific embodiment, the intelligent follow-up system can synchronize follow-up data in real time. At the same time, the intelligent follow-up system comes with professional statistical analysis functions. All follow-up data and patient feedback information automatically generate icons and are updated in real time, providing extremely powerful technical support for doctors' academic research.
[0075] In a specific embodiment, the intelligent follow-up system supports the export of follow-up data. When all data have been screened, the user can use the "Export Data" button to organize the case file into an Excel detailed document for export. The specific content of the Excel table includes a page list. In order to protect the personal privacy information of the case, the name, follow-up name, ID number, and follow-up phone number of the exported Excel information are encrypted and displayed. When exporting Excel table data, there are multiple conditions for screening control, including: Retrieval control: The exported visit data will be filtered and exported according to the retrieval conditions. It should be noted that advanced retrieval and general retrieval are the same; Visit control: In project management, the exported Excel table data will be subject to the scope of the visit. For example, if the "Basic Situation Registration" visit is selected, only the case information under the visit can be exported, with the exception of "Visit Data Export". If all visit content is exported, you need to select "Unlimited Visits" to export the data.
[0076] Follow-up items are matched with follow-up targets, and follow-up items are analyzed cyclically for follow-up targets.
[0077] Specifically, the follow-up target is matched with follow-up items, and the specific analysis process is: obtaining the follow-up target comprehensive matching value of the follow-up target, matching the follow-up target comprehensive matching value of the follow-up target with the follow-up target comprehensive matching value interval corresponding to each follow-up item stored in the medical information library, obtaining the follow-up item corresponding to the follow-up target, and incorporating the follow-up target into the corresponding follow-up item.
[0078] In a specific embodiment, the cases of the project are automatically managed through the sorting operation, without the need to manually find related cases for adding and removing and other tedious operations. The execution time of automatic sorting in the intelligent follow-up system is 1 o'clock in the evening.
[0079] Inclusion settings interface: In "Project Management", click "Project Design-Inclusion Settings-Add Inclusion Conditions", fill in the title and select the project source, click OK, and an initial condition set of the inclusion condition template will be added below, completing the template addition of the inclusion condition. It should be noted that "Unlimited Projects" of the project source refers to the inclusion of cases from case management, and other project names refer to a project in the group as the inclusion target, and each project is only allowed to have 5 condition modules.
[0080] Exclusion setting interface: Click the "Add exclusion condition" button to add an exclusion condition module, and exclude cases according to the conditions set in the module, so as to automatically eliminate cases that do not meet the project requirements. The specific operation is the same as that in the inclusion setting. It should be noted that the cases in the current project are excluded.
[0081] After editing the inclusion and exclusion conditions, you can perform manual immediate execution operations in data analysis. Execute inclusion operations: immediately add items according to the "inclusion settings" conditions; execute exclusion operations: immediately exclude items according to the "exclusion settings" conditions. If there is no inclusion and exclusion condition, there will be an error prompt reminder, and complete the operation according to the reminder.
[0082] It should be explained that the follow-up mentioned in this embodiment is a medical term, which refers to regular or irregular observation, visits, evaluation and guidance of follow-up targets or specific populations who have received medical services in order to understand their health status, disease progression, treatment effects, quality of life and satisfaction, etc., as well as providing necessary medical care, preventive care, research or management services. The content and frequency of medical follow-up are customized and adjusted according to different diseases, conditions, goals, resources and risks. Medical follow-up is an important part of medical services and is of great significance for improving medical quality, protecting the interests of follow-up targets, promoting doctor-patient relationships, and promoting medical development.
[0083] It should be explained that the project inclusion mentioned in this embodiment is a process of determining which activities, tasks, results or stakeholders should be included or excluded in the project based on the project's objectives, scope, resources and risks. In the present invention, each stable follow-up status is defined as a follow-up project.
[0084] In a specific embodiment, when the situation of the follow-up target changes, the follow-up target will exit the current follow-up project according to the exclusion attribute of its current follow-up project, and will enter one or more new follow-up projects according to its new situation and the inclusion attribute of all available follow-up projects. In this way, the follow-up target will switch between different follow-up projects to form a meshed and directional follow-up state transformation diagram. This follow-up state transformation diagram is the follow-up path. The follow-up path is an important reference for disease treatment, disease change prediction, development trend, etc. The present invention clarifies a method for generating a follow-up path based on the inclusion and exclusion attributes of the follow-up project. This dynamic follow-up path generated based on the project attribute definition can truly reflect the time series of disease changes, and has important guiding significance for indicating the risk of disease progression, optimizing treatment plans, and individualized follow-up recommendations.
[0085] In a specific embodiment, a follow-up path definition method and system are provided, and a parameter calculation method is provided by obtaining the physical condition data of the follow-up target, and a comprehensive follow-up target comprehensive matching value of the follow-up target is comprehensively calculated, wherein the comprehensive matching of the follow-up target includes physical condition data collection and medication status investigation, and the reference standard values of various physical indicators of the follow-up target are matched according to the basic information and body mass index of the follow-up target, and personalized follow-up examinations are provided, and follow-up investigations are conducted on the medication status of the follow-up target, so as to timely understand and supervise the medication status of the follow-up target and improve the effect of drug treatment.
[0086] Reference Figure 2 As shown, the second aspect of the present invention provides a follow-up path definition system, including: a follow-up target status analysis module, a follow-up item matching module and a medical information library.
[0087] The follow-up target status analysis module is connected to the follow-up item matching module, and both the follow-up target status analysis module and the follow-up item matching module are connected to the medical information database.
[0088] The follow-up target status analysis module is used to analyze the follow-up target status and calculate the follow-up target comprehensive matching value of the follow-up target, and the follow-up target comprehensive matching value is used to reflect the matching degree between the follow-up target information data and the follow-up items.
[0089] The follow-up item matching module is used to match the follow-up items to the follow-up targets and to perform a follow-up item cyclic analysis on the follow-up targets.
[0090] The medical information database is used to store reference standard values of various physical indicators corresponding to each label follow-up target within each body mass index interval, and comprehensive matching value intervals of follow-up targets corresponding to each follow-up item.
[0091] The above contents are merely examples and explanations of the structure of the present invention. The technicians in this technical field may make various modifications or additions to the specific embodiments described or replace them in a similar manner. As long as they do not deviate from the structure of the invention or exceed the scope defined by the claims, they should all fall within the protection scope of the present invention.
Claims
1. A method for defining a follow-up path, It is characterized in that include: Step 1: Analyze the status of the follow-up target and calculate the comprehensive matching value of the follow-up target, where the comprehensive matching value of the follow-up target is used to reflect the matching degree between the follow-up target information data and the follow-up items; Step 2: Match the follow-up items to the follow-up targets, and conduct a circular analysis of the follow-up items for the follow-up targets; The specific analysis process of matching the follow-up items to the follow-up targets is as follows: Obtaining a comprehensive matching value of a follow-up target of a follow-up target, matching the comprehensive matching value of the follow-up target of the follow-up target with a comprehensive matching value interval of a follow-up target corresponding to each follow-up item stored in a medical information database, obtaining a follow-up item corresponding to the follow-up target, and incorporating the follow-up target into the corresponding follow-up item; The specific calculation formula for calculating the comprehensive matching value of the follow-up target is as follows: In the formula, β represents the comprehensive matching value of the follow-up target, α 征 and α 药 They represent the matching index of the physical sign data and the matching index of the medication data of the follow-up target, e represents the natural constant, ζ 1 and 2 They respectively represent the comprehensive matching influencing factors corresponding to the set physical sign data matching index and the drug administration data matching index; The calculation expression of the physical sign data matching degree index is: a 征 =ln(x 生 *ψ 1 +x 动 *ψ 2 +1), In the formula, α 征 Indicates the matching degree index of physical sign data, χ 生 and χ 动 They represent the matching evaluation value of the vital sign data and the matching evaluation value of the motion data of the follow-up target, ψ 1 and ψ 2 They respectively represent the basic vital sign influencing factors corresponding to the set vital sign data matching evaluation value and the motion data matching degree evaluation value; The vital sign data matching evaluation value, the specific analysis and calculation process is as follows: Obtain the vital signs data of the follow-up target, deploy several detection time points within the set detection cycle, obtain the heart rate data, body temperature data and blood pressure data of the follow-up target at each detection time point, and comprehensively calculate the vital signs data matching evaluation value. The calculation expression is: In the formula, χ 生 Represents the vital signs data matching evaluation value, Hr i , Bt i and Bp i Respectively represent the heart rate, body temperature and blood pressure of the follow-up target at the i-th detection time point, HR 0 , Bt 0 and Bp 0 They represent the reference standard heart rate, reference standard body temperature and reference standard blood pressure respectively. ΔHr, ΔBt and ΔBp represent the set limit deviation heart rate, limit deviation body temperature and limit deviation blood pressure respectively. 1 , 2 and 3 They represent the abnormal vital sign influencing factors corresponding to the set heart rate, body temperature and blood pressure, respectively. i represents the number of each detection time point, i=1,2,3,...,n, and n represents the total number of detection time points; The specific analysis process of the motion data matching degree evaluation value is as follows: The exercise data of the follow-up target was obtained through investigation, including the exercise duration and number of steps of the follow-up target on each exercise day, and the evaluation value of the exercise data matching degree was comprehensively calculated. The calculation expression is: In the formula, χ 动 Represents the motion data matching evaluation value, and Respectively represent the exercise duration and number of exercise steps on the dth exercise day, and Respectively represent the reference standard daily exercise duration and reference standard daily exercise steps, ΔT 动 and ΔN 步 Respectively represent the set limit deviation movement duration and limit deviation movement steps, ω 1 and ω 2 They represent the influencing factors of the matching degree of exercise data corresponding to the set exercise duration and exercise steps, d represents the number of each exercise day, d=1,2,3,...,f, and f represents the total number of exercise days; The calculation expression of the drug administration data matching degree index is: In the formula, α 药 represents the matching index of drug administration data, χ 反 and χ 依 Represent the abnormal drug response value and drug compliance assessment value, respectively. and They respectively represent the abnormal medication effect factors corresponding to the set abnormal drug reaction values and drug compliance assessment values; The specific analysis process of the abnormal drug reaction value is as follows: Deploy several time screening points to obtain the blood oxygen saturation of the follow-up target at each time screening point during medication, and at the same time detect the average heart rate and average blood pressure of the follow-up target after each medication; Obtain the follow-up target's sleep duration and number of awakenings at night on each medication day; Calculate the abnormal physical sign evaluation value after taking the medicine, and its calculation expression is: Calculate the abnormal sleep quality evaluation value after taking the medicine, and its calculation expression is: The drug reaction abnormality value is calculated comprehensively, and the calculation expression is: In the formula, δ 体 Indicates the evaluation value of abnormal physical signs after taking the medicine. N represents the blood oxygen saturation of the follow-up target at the pth time screening point during medication. 0 represents the reference standard blood oxygen saturation after taking the drug, ΔN represents the set blood oxygen saturation limit deviation, σ represents the abnormal drug reaction influencing factor corresponding to the set blood oxygen saturation, and Respectively represent the average heart rate and average blood pressure of the follow-up target after the tth medication, HR 0 and Bp 0 Respectively represent the reference standard heart rate and reference standard blood pressure, ΔHr″ and ΔBp″ represent the set medication deviation heart rate and medication deviation blood pressure, p represents the number of each time screening point, p=1,2,3,...,z, z represents the total number of time screening points, t represents the number of each medication, t=1,2,3,...,s, s represents the total number of medications, δ 睡 It indicates the abnormal sleep quality assessment value after taking the medicine. represents the sleep duration of the follow-up target on the qth medication day, Indicates the reference standard sleep duration during medication, ΔT 睡 Indicates the allowable deviation of the sleep duration during medication. represents the number of wakefulness at night on the qth medication day of the follow-up target, Indicates the sleep quality influencing factor corresponding to the set sleep duration. represents the sleep quality impact factor corresponding to a set single night awakening, q represents the number of each medication day, q = 1, 2, 3, ..., k, k represents the total number of medication days, χ 反 represents the abnormal value of drug response, θ 1 and θ 2 They respectively represent the abnormal drug reaction influencing factors corresponding to the set abnormal physical sign evaluation value after taking the medicine and the abnormal sleep quality evaluation value after taking the medicine; The specific analysis process of the drug compliance evaluation value is as follows: Set a follow-up period and obtain the time interval and dosage of each medication for the follow-up target within the period; The drug compliance evaluation value is calculated comprehensively, and the calculation expression is: In the formula, χ 依 represents the medication compliance assessment value, T rt and Q rt T represents the time interval and dosage of the tth medication of the rth drug, respectively. r0 and Q r0 They represent the reference standard medication time interval and medication dosage of the r-th category drug, ΔT and ΔQ represent the set limit deviation medication time interval and limit deviation medication dosage, respectively. and They respectively represent the drug compliance influencing factors corresponding to the set medication time interval and medication dosage.
2. A follow-up path definition method according to claim 1, Features: The following analysis is performed on the target status of the follow-up visit, and the specific analysis process is as follows: Obtain the basic information of the follow-up target, including the gender, age, height and weight data of the follow-up target, generate a specified label for the gender and age of the follow-up target, and use the formula Calculate the body mass index of the follow-up target, where BMI represents the body mass index of the follow-up target, and H and W represent the height and weight of the follow-up target, respectively; The body mass index of the follow-up target is matched with the reference standard values of various physical indicators corresponding to each labeled follow-up target in each body mass index range stored in the medical information database to obtain the reference standard values of various physical indicators of the follow-up target, including the reference standard heart rate, reference standard body temperature, reference standard blood pressure, reference standard daily exercise duration, reference standard daily exercise steps, reference standard blood oxygen saturation after taking medication, reference standard sleep duration during medication, reference standard medication time interval and medication dosage.
3. A follow-up path definition system, applying the follow-up path definition method as claimed in any one of claims 1 to 2, Features: include: A follow-up target status analysis module is used to analyze the follow-up target status and calculate the follow-up target comprehensive matching value of the follow-up target, wherein the follow-up target comprehensive matching value is used to reflect the matching degree between the follow-up target information data and the follow-up items; A follow-up project matching module is used to match follow-up projects with follow-up targets and perform a follow-up project cycle analysis on the follow-up targets; The medical information database is used to store the reference standard values of various physical indicators corresponding to each label follow-up target in each body mass index interval, and the comprehensive matching value interval of the follow-up target corresponding to each follow-up item.
